Concepedia

Boudewijn L. M. de Jonge

BL

Statistics

Publications

28

Citations

1.9K

H-Index

24

Active since

1993

Affiliations

AstraZeneca (United States)(Current)

Rockefeller University

Pfizer (United States)

AstraZeneca (United Kingdom)

Michigan State University

Boudewijn L. M. de Jonge is an author at AstraZeneca (United States) specializing in life sciences, microbiology, and antimicrobial resistance.

Publications per year

1993–2021

28

Publications

28

<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015

James A. Karlowsky, Krystyna M. Kazmierczak, Boudewijn L. M. de Jonge et al. · Antimicrobial Agents and Chemotherapy · 2017 · 190 citations · Full text

, , +17

<i>In Vitro</i> Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014)

Wright W. Nichols, Boudewijn L. M. de Jonge, Krystyna M. Kazmierczak et al. · Antimicrobial Agents and Chemotherapy · 2016 · 165 citations · Full text

, , +16

<i>In Vitro</i> Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)

Boudewijn L. M. de Jonge, James A. Karlowsky, Krystyna M. Kazmierczak et al. · Antimicrobial Agents and Chemotherapy · 2016 · 158 citations · Full text

, , +17

Exploitation of structural and regulatory diversity in glutamate racemases

T. Lundqvist, Stewart L. Fisher, Günther Kern et al. · Nature · 2007 · 141 citations · Full text

, , +5

Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible <i>Enterobacterales</i> Collected as Part of a Global Surveillance Program, 2012 to 2017

Krystyna M. Kazmierczak, James A. Karlowsky, Boudewijn L. M. de Jonge et al. · Antimicrobial Agents and Chemotherapy · 2021 · 108 citations · Full text

, , +17

1–5 of 28